EGLIN C BASED DRUGS FOR TREATMENT OF DISEASE

Details for Australian Patent Application No. 2002322263 (hide)

Owner REGENTS OF THE UNIVERSITY OF MICHIGAN

Inventors FULLER, Robert, S.; KOMIYAMA, Tomoko

Pub. Number AU-A-2002322263

PCT Number PCT/US02/19394

PCT Pub. Number WO2002/102318

Priority 60/299,096 18.06.01 US; Not Given 17.06.02 US

Filing date 18 June 2002

Wipo publication date 2 January 2003

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 60/299,096 18.06.01 US; Not Given 17.06.02 US

15 May 2003 Application Open to Public Inspection

  Published as AU-A-2002322263

11 March 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002322264-POLYNUCLEOTIDE ENCODING A NOVEL HUMAN GROWTH FACTOR WITH HOMOLOGY TO EPIDERMAL GROWTH FACTOR, BGS-8, EXPRESSED HIGHLY IN IMMUNE TISSUE

2002322262-STRUCTURES AND METHODS FOR A HIGH-SPEED SEMICONDUCTOR DEVICE